Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
Real-time Quote. Real-time Cboe BZX - 01/21 08:45:37 am
87.45 USD   -0.62%
01/20ABBVIE : Form 8.3 - Abbvie Inc
DJ
01/17ABBVIE : Form 8.3 - -2-
DJ
01/17ABBVIE : Form 8.3 -
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AbbVie Inc.
AbbVie specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease.

Sales are distributed geographically as follows: the United States (65.7%), Japan (4.9%), Germany (3.9%), the United Kingdom (2.6%), France (2.4%), Canada (2.2%) , Italy (2%), Spain (1.9%), the Netherlands (1.1%), Brazil (1.1%), and other (12.2%).

Number of employees : 30 000 people.
Sales per Businesses
20172018Delta
USD (in Million)%USD (in Million)%
HUMIRA18,42765.3%19,93660.9% +8.19%
IMBRUVICA2,5739.1%3,59011% +39.53%
HCV1,2744.5%---
All Other998.003.5%319.001% -68.04%
Creon831.002.9%928.002.8% +11.67%
Lupron829.002.9%892.002.7% +7.6%
Synthroid781.002.8%776.002.4% -0.64%
Synagis738.002.6%726.002.2% -1.63%
AndroGel577.002%469.001.4% -18.72%
Kaletra423.001.5%336.001% -20.57%
Sevoflurane410.001.5%391.001.2% -4.63%
Duodopa355.001.3%430.001.3% +21.13%
MAVYRET--3,43810.5%-
VENCLEXTA--344.001.1%-
VIEKIRA--178.000.5%-
Sales per Regions
20172018Delta
USD (in Million)%USD (in Million)%
United States18,25164.7%21,52465.7% +17.93%
All Other Countries4,08014.5%4,01312.3% -1.64%
Germany1,1574.1%1,2923.9% +11.67%
United Kingdom807.002.9%855.002.6% +5.95%
Japan764.002.7%1,5914.9% +108.25%
France730.002.6%783.002.4% +7.26%
Canada659.002.3%730.002.2% +10.77%
Spain521.001.8%611.001.9% +17.27%
Italy475.001.7%652.002% +37.26%
Brazil410.001.5%350.001.1% -14.63%
Netherlands362.001.3%352.001.1% -2.76%
Managers
NameAgeSinceTitle
Richard Gonzalez652013Chairman & Chief Executive Officer
Michael Severino542018Vice Chairman & President
Azita Saleki-Gerhardt552018Executive Vice President-Operations
Robert A. Michael492018Chief Financial Officer & Senior Vice President
Carlos Alban572018Vice Chairman & Chief Commercial Officer
Robert J. Alpern, Dr.682013Independent Director
Roxanne Austin582013Independent Director
William H. L. Burnside672013Independent Director
Edward Michael Liddy732013Independent Director
Edward J. Rapp612013Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 1,781,515,185 1,477,504,080 82.9% 302,647,520 17.0% 82.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 119,629,462 8.09%
Capital Research & Management Co. (Global Investors) 94,861,327 6.41%
SSgA Funds Management, Inc. 69,033,038 4.67%
BlackRock Fund Advisors 36,874,996 2.49%
Fidelity Management & Research Co. 33,981,940 2.30%
Geode Capital Management LLC 23,746,994 1.61%
T. Rowe Price Associates, Inc. (Investment Management) 19,778,555 1.34%
Northern Trust Investments, Inc.(Investment Management) 19,630,634 1.33%
Orbis Investment Management Ltd. 17,059,987 1.15%
Norges Bank Investment Management 14,106,418 0.95%
Markets and indexes
- NYSE
- Main Market
- SP 100 / SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  ABBV.N
- Datastream Code :  
Company contact information
AbbVie Inc.
1 Road North Waukegan
IL 60064 North Chicago, Illinois
États-Unis (les)

Phone : +1 847 932 7900
Fax : +1
Internet : http://www.abbvie.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AbbVie Inc.
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ABBVIE INC.-0.61%130 136
JOHNSON & JOHNSON2.26%392 596
ROCHE HOLDING AG4.44%289 068
MERCK AND COMPANY0.02%231 608
PFIZER3.39%224 187
NOVARTIS0.96%216 654
BRISTOL-MYERS SQUIBB COMPANY3.94%156 404
NOVO NORDISK AS6.96%144 481
AMGEN0.17%143 489
ELI LILLY AND COMPANY6.20%134 015
ASTRAZENECA3.02%133 679
SANOFI2.54%127 703
GLAXOSMITHKLINE3.32%118 266
BAYER AG3.69%82 204
ALLERGAN PLC0.79%63 252
TAKEDA PHARMACEUTICAL COMPANY LIMITED3.26%62 746
JIANGSU HENGRUI MEDICINE CO., LTD.3.59%57 784
CHUGAI PHARMACEUTICAL CO., LTD.6.75%53 051
DAIICHI SANKYO COMPANY, LIMITED2.66%43 185
ASTELLAS PHARMA INC.1.65%31 869
EISAI CO., LTD.3.29%21 719